Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC

This publication has 16 references indexed in Scilit:

• Cancer predisposition: Where's the phosphate?
  Current Biology, 1998
• Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
  Proceedings of the National Academy of Sciences, 1997
• Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase
  Science, 1997
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
  Nature Genetics, 1997
• PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
  Science, 1997
• PI3K: Downstream AKTion Blocks Apoptosis
  Cell, 1997
• Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
  Proceedings of the National Academy of Sciences, 1996
• Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
  International Journal of Cancer, 1995
• Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.
  Proceedings of the National Academy of Sciences, 1987
• Radiation therapy for neoplasms of the brain
  Journal of Neurosurgery, 1987